Stonegate Pharmaceutical Group

Stonegate Pharmaceutical Group is a specialty pharmaceutical company focused on the development, registration, and commercialization of innovative healthcare products within the Greater China market. The company acts as a strategic bridge for international biotechnology and pharmaceutical firms, offering comprehensive services that include NMPA regulatory strategy, clinical trial management, and market access. Stonegate specializes in high-barrier therapeutic areas such as orphan drugs, pediatric medicine, and complex formulations, providing end-to-end solutions from licensing to distribution. By leveraging deep local expertise and a robust regulatory track record, the group facilitates the entry of global life science innovations into one of the world's fastest-growing healthcare sectors.